Showing results (31-40 of 278) with videos related to

Sort By:
Pageof 28
Tuberculosis (Edinburgh, Scotland)|March 12, 2011
Discriminating between latent and active tuberculosis with multiple biomarker responsesMarc Frahm, Neela D Goswami, Kouros Owzar, et al.
Plos One|October 3, 2013
High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllersOlivier Lambotte, Justin Pollara, Faroudy Boufassa, et al.
BMC Immunology|August 29, 2023
HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfectionAndrew Ekii Obuku, Jacqueline Kyosiimire Lugemwa, Andrew Abaasa, et al.
Open Forum Infectious Diseases|July 12, 2018
Markers of Tissue Repair and Cellular Aging Are Increased in the Liver Tissue of Patients With HIV Infection Regardless of Presence of HCV CoinfectionSusanna Naggie, Marzena Swiderska-Syn, Steve Choi, et al.
Frontiers in Immunology|November 22, 2021
FlowKit: A Python Toolkit for Integrated Manual and Automated Cytometry Analysis WorkflowsScott White, John Quinn, Jennifer Enzor, et al.
AIDS Research and Human Retroviruses|October 21, 2011
Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentationGretchen S Arnoczy, Guido Ferrari, Nilu Goonetilleke, et al.
Annali Italiani Di Chirurgia|March 15, 2008
[The sentinel lymph node biopsy. Evolution and convalidation of the technique]Paolo Antonino Riccio, Pierangela Marabini, Stefano Seracchioli, et al.
Frontiers in Immunology|September 6, 2021
Elimination of SHIV Infected Cells by Combinations of Bispecific HIVxCD3 DART® MoleculesMarina Tuyishime, Amir Dashti, Katelyn Faircloth, et al.
Journal of Immunological Methods|January 17, 2002
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJeffrey R Currier, Ellen G Kuta, Ellen Turk, et al.
The Journal of Clinical Investigation|June 26, 2020
Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodiesMarina Tuyishime, Carolina Garrido, Shalini Jha, et al.
Pageof 28